Cubist Systematic Strategies, LLC Intellia Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 188,316 shares of NTLA stock, worth $2.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

188,316

Holding current value

$2.29 Million

% of portfolio

0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $3.71 Million - $5.15 Million	188,316 New	188,316 $3.87 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $98,066 - $135,037	4,117 Added 21.62%	23,159 $637,000
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $111,029 - $155,037	-4,794 Reduced 20.11%	19,042 $580,000
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $753,694 - $1.09 Million	23,836 New	23,836 $753,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $1.79 Million - $2.41 Million	-53,756 Reduced 31.41%	117,395 $4.38 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $2.78 Million - $5.25 Million	83,784 Added 95.9%	171,151 $5.97 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $15,043 - $20,004	279 Added 0.32%	87,367 $4.89 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $2.91 Million - $5.75 Million	75,499 Added 651.47%	87,088 $4.51 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $675,291 - $1.38 Million	11,589 New	11,589 $842,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $2.1 Million - $2.88 Million	-20,830 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $229,397 - $306,359	1,733 Added 9.07%	20,830 $2.79 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $1.02 Million - $2.71 Million	16,741 Added 710.57%	19,097 $3.09 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $1.99 Million - $3.58 Million	-42,807 Reduced 94.78%	2,356 $189,000
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $28,150 - $94,977	-1,495 Reduced 3.2%	45,163 $2.46 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $236,561 - $337,577	-13,541 Reduced 22.49%	46,658 $928,000
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $670,616 - $1.38 Million	60,199 New	60,199 $1.27 Million
Q2 2019 Aug 14, 2019	SELL	$13.88 - $18.41 $139,119 - $184,523	-10,023 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.79 - $17.62 $558,232 - $769,042	-43,646 Reduced 81.32%	10,023 $171,000
Q4 2018 Feb 14, 2019	BUY	$11.39 - $27.13 $548,713 - $1.31 Million	48,175 Added 876.87%	53,669 $733,000
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $184,559 - $233,383	-7,159 Reduced 56.58%	5,494 $157,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $14,194 - $21,830	709 Added 5.94%	12,653 $346,000
Q1 2018 May 15, 2018	BUY	$19.43 - $34.95 $232,071 - $417,442	11,944 New	11,944 $252,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Intellia Therapeutics, Inc. Transaction History